• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

4-1BB 缺陷导致的免疫缺陷和 EBV 诱导的淋巴组织增生。

Immunodeficiency and EBV-induced lymphoproliferation caused by 4-1BB deficiency.

机构信息

Division of Immunology, Boston Children's Hospital, and the Department of Pediatrics, Harvard Medical School, Boston, Mass; Department of Pediatrics, King Saud University, Riyadh, Saudi Arabia.

Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany.

出版信息

J Allergy Clin Immunol. 2019 Aug;144(2):574-583.e5. doi: 10.1016/j.jaci.2019.03.002. Epub 2019 Mar 11.

DOI:10.1016/j.jaci.2019.03.002
PMID:30872117
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6688916/
Abstract

BACKGROUND

The tumor TNF receptor family member 4-1BB (CD137) is encoded by TNFRSF9 and expressed on activated T cells. 4-1BB provides a costimulatory signal that enhances CD8 T-cell survival, cytotoxicity, and mitochondrial activity, thereby promoting immunity against viruses and tumors. The ligand for 4-1BB is expressed on antigen-presenting cells and EBV-transformed B cells.

OBJECTIVE

We investigated the genetic basis of recurrent sinopulmonary infections, persistent EBV viremia, and EBV-induced lymphoproliferation in 2 unrelated patients.

METHODS

Whole-exome sequencing, immunoblotting, immunophenotyping, and in vitro assays of lymphocyte and mitochondrial function were performed.

RESULTS

The 2 patients shared a homozygous G109S missense mutation in 4-1BB that abolished protein expression and ligand binding. The patients' CD8 T cells had reduced proliferation, impaired expression of IFN-γ and perforin, and diminished cytotoxicity against allogeneic and HLA-matched EBV-B cells. Mitochondrial biogenesis, membrane potential, and function were significantly reduced in the patients' activated T cells. An inhibitory antibody against 4-1BB recapitulated the patients' defective CD8 T-cell activation and cytotoxicity against EBV-infected B cells in vitro.

CONCLUSION

This novel immunodeficiency demonstrates the critical role of 4-1BB costimulation in host immunity against EBV infection.

摘要

背景

肿瘤坏死因子受体超家族成员 4-1BB(CD137)由 TNFRSF9 编码,表达于活化的 T 细胞上。4-1BB 提供共刺激信号,增强 CD8 T 细胞的存活、细胞毒性和线粒体活性,从而促进机体对病毒和肿瘤的免疫应答。4-1BB 的配体表达于抗原呈递细胞和 EBV 转化的 B 细胞上。

目的

我们研究了 2 例无关联患者反复发生的肺-鼻窦感染、持续性 EBV 病毒血症和 EBV 诱导的淋巴增生的遗传基础。

方法

进行了全外显子组测序、免疫印迹、免疫表型分析以及淋巴细胞和线粒体功能的体外检测。

结果

这 2 例患者共享 4-1BB 基因中的纯合 G109S 错义突变,导致蛋白表达和配体结合缺失。患者的 CD8 T 细胞增殖减少,IFN-γ和穿孔素表达受损,对同种异体和 HLA 匹配的 EBV-B 细胞的细胞毒性作用降低。患者活化 T 细胞中的线粒体生物发生、膜电位和功能显著降低。4-1BB 的抑制性抗体在体外重现了患者 CD8 T 细胞对 EBV 感染的 B 细胞的激活缺陷和细胞毒性缺陷。

结论

这种新型免疫缺陷症表明 4-1BB 共刺激在宿主对 EBV 感染的免疫应答中起着关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba8/6688916/21d5371118a8/nihms-1524391-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba8/6688916/0b39b5bfc20d/nihms-1524391-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba8/6688916/64f5f988df4c/nihms-1524391-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba8/6688916/7ad05a87d4b8/nihms-1524391-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba8/6688916/21d5371118a8/nihms-1524391-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba8/6688916/0b39b5bfc20d/nihms-1524391-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba8/6688916/64f5f988df4c/nihms-1524391-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba8/6688916/7ad05a87d4b8/nihms-1524391-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba8/6688916/21d5371118a8/nihms-1524391-f0004.jpg

相似文献

1
Immunodeficiency and EBV-induced lymphoproliferation caused by 4-1BB deficiency.4-1BB 缺陷导致的免疫缺陷和 EBV 诱导的淋巴组织增生。
J Allergy Clin Immunol. 2019 Aug;144(2):574-583.e5. doi: 10.1016/j.jaci.2019.03.002. Epub 2019 Mar 11.
2
Concomitant and deficiencies cause chronic active Epstein-Barr virus infection of T cells.并发和缺陷导致 T 细胞慢性活动性 Epstein-Barr 病毒感染。
J Exp Med. 2019 Dec 2;216(12):2800-2818. doi: 10.1084/jem.20190678. Epub 2019 Sep 19.
3
Gene-corrected human Munc13-4-deficient CD8+ T cells can efficiently restrict EBV-driven lymphoproliferation in immunodeficient mice.基因校正的人类Munc13-4缺陷型CD8 + T细胞可有效抑制免疫缺陷小鼠中EBV驱动的淋巴细胞增殖。
Blood. 2016 Dec 15;128(24):2859-2862. doi: 10.1182/blood-2016-07-729871. Epub 2016 Oct 31.
4
Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP.SAP 杂合表达女性携带者中揭示的 XLP 中 EBV 易感性的分子发病机制。
PLoS Biol. 2011 Nov;9(11):e1001187. doi: 10.1371/journal.pbio.1001187. Epub 2011 Nov 1.
5
Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27.缺乏功能性 CD27 的患者出现危及生命的 EBV 相关淋巴组织增生性疾病合并免疫缺陷
Haematologica. 2013 Mar;98(3):473-8. doi: 10.3324/haematol.2012.068791. Epub 2012 Jul 16.
6
Epstein-Barr virus-specific T-cell cytotoxicity is mediated through the perforin pathway in patients with lymphoproliferative disorders after allogeneic bone marrow transplantation.在异基因骨髓移植后发生淋巴增殖性疾病的患者中,爱泼斯坦-巴尔病毒特异性T细胞的细胞毒性是通过穿孔素途径介导的。
Br J Haematol. 2002 Mar;116(3):710-5. doi: 10.1046/j.0007-1048.2001.03299.x.
7
Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunity.激活 PIK3CD 突变会损害人类细胞毒性淋巴细胞的分化和功能,并影响 EBV 免疫。
J Allergy Clin Immunol. 2019 Jan;143(1):276-291.e6. doi: 10.1016/j.jaci.2018.04.030. Epub 2018 May 22.
8
Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases.T 细胞介导的针对 Epstein-Barr 病毒免疫的信号通路:来自遗传疾病的启示。
Immunol Rev. 2019 Sep;291(1):174-189. doi: 10.1111/imr.12791.
9
Successful hematopoietic stem cell transplantation in a 4-1BB deficient patient with EBV-induced lymphoproliferation.4-1BB 缺陷患者发生 EBV 诱导的淋巴组织增生后行造血干细胞移植获得成功。
Clin Immunol. 2021 Jan;222:108639. doi: 10.1016/j.clim.2020.108639. Epub 2020 Nov 28.
10
Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency.遗传性CD70缺陷患者的联合免疫缺陷与爱泼斯坦-巴尔病毒诱导的B细胞恶性肿瘤
J Exp Med. 2017 Jan;214(1):91-106. doi: 10.1084/jem.20160849. Epub 2016 Dec 23.

引用本文的文献

1
Clinical and functional characterization of a novel variant causing immune dysregulation with predisposition to EBV-driven lymphomagenesis.一种导致免疫失调并易患EBV驱动淋巴瘤发生的新型变异体的临床和功能特征
Front Immunol. 2025 Aug 6;16:1605221. doi: 10.3389/fimmu.2025.1605221. eCollection 2025.
2
Role of IL-27 in Epstein-Barr virus infection revealed by IL-27RA deficiency.IL-27RA 缺陷揭示了 IL-27 在 Epstein-Barr 病毒感染中的作用。
Nature. 2024 Apr;628(8008):620-629. doi: 10.1038/s41586-024-07213-6. Epub 2024 Mar 20.
3
Mechanisms of T cell evasion by Epstein-Barr virus and implications for tumor survival.

本文引用的文献

1
4-1BB enhancement of CAR T function requires NF-κB and TRAFs.4-1BB 增强 CAR T 功能需要 NF-κB 和 TRAFs。
JCI Insight. 2018 Sep 20;3(18). doi: 10.1172/jci.insight.121322.
2
Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases.遗传性免疫缺陷病伴高易感性的 EBV 驱动的淋巴增殖性疾病。
Front Immunol. 2018 Jun 4;9:1103. doi: 10.3389/fimmu.2018.01103. eCollection 2018.
3
Crystal structures of the human 4-1BB receptor bound to its ligand 4-1BBL reveal covalent receptor dimerization as a potential signaling amplifier.
EB 病毒逃避免疫监测的机制及其对肿瘤存活的影响。
Front Immunol. 2023 Dec 21;14:1289313. doi: 10.3389/fimmu.2023.1289313. eCollection 2023.
4
4-1BB immunotherapy: advances and hurdles.4-1BB 免疫疗法:进展与障碍。
Exp Mol Med. 2024 Feb;56(1):32-39. doi: 10.1038/s12276-023-01136-4. Epub 2024 Jan 4.
5
Cytotoxic peripheral T-cell lymphomas and EBV-positive T/NK-cell lymphoproliferative diseases: emerging concepts, recent advances, and the putative role of clonal hematopoiesis. A report of the 2022 EA4HP/SH lymphoma workshop.细胞毒性外周 T 细胞淋巴瘤和 EBV 阳性 T/NK 细胞淋巴增生性疾病:新出现的概念、最新进展,以及克隆性造血的推测作用。2022 年 EA4HP/SH 淋巴瘤研讨会报告。
Virchows Arch. 2023 Sep;483(3):333-348. doi: 10.1007/s00428-023-03616-4. Epub 2023 Aug 30.
6
Fundamental Characterization of Antibody Fusion-Single-Chain TNF Recombinant Proteins Directed against Costimulatory TNF Receptors Expressed by T-Lymphocytes.针对表达于 T 淋巴细胞的共刺激 TNF 受体的抗体融合 - 单链 TNF 重组蛋白的基本特性鉴定。
Cells. 2023 Jun 9;12(12):1596. doi: 10.3390/cells12121596.
7
Delivering co-stimulatory tumor necrosis factor receptor agonism for cancer immunotherapy: past, current and future perspectives.提供共刺激肿瘤坏死因子受体激动剂用于癌症免疫治疗:过去、现在和未来的观点。
Front Immunol. 2023 Apr 25;14:1147467. doi: 10.3389/fimmu.2023.1147467. eCollection 2023.
8
CD137 deficiency because of two novel biallelic mutations in a patient presenting with severe EBV-associated lymphoproliferative disease.一名患有严重EB病毒相关淋巴增殖性疾病的患者因两个新的双等位基因突变导致CD137缺乏。
Clin Transl Immunology. 2023 May 2;12(5):e1448. doi: 10.1002/cti2.1448. eCollection 2023.
9
Genetic lesions and targeted therapy in Hodgkin lymphoma.霍奇金淋巴瘤中的基因损伤与靶向治疗
Ther Adv Hematol. 2023 Jan 12;14:20406207221149245. doi: 10.1177/20406207221149245. eCollection 2023.
10
When to suspect inborn errors of immunity in Epstein-Barr virus-related lymphoproliferative disorders.怀疑 EBV 相关淋巴组织增生性疾病存在先天性免疫缺陷时该如何处理。
Clin Microbiol Infect. 2023 Apr;29(4):457-462. doi: 10.1016/j.cmi.2022.10.003. Epub 2022 Oct 6.
人源 4-1BB 受体与其配体 4-1BBL 结合的晶体结构揭示了共价受体二聚化作为一种潜在的信号放大机制。
J Biol Chem. 2018 Jun 29;293(26):9958-9969. doi: 10.1074/jbc.RA118.003176. Epub 2018 May 2.
4
Mitochondrial Morphological and Functional Reprogramming Following CD137 (4-1BB) Costimulation.CD137(4-1BB)共刺激后线粒体形态和功能的重编程。
Cancer Immunol Res. 2018 Jul;6(7):798-811. doi: 10.1158/2326-6066.CIR-17-0767. Epub 2018 Apr 20.
5
4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses.4-1BB 共刺激诱导 T 细胞线粒体功能和生物发生,从而实现癌症免疫治疗反应。
J Exp Med. 2018 Apr 2;215(4):1091-1100. doi: 10.1084/jem.20171068. Epub 2018 Mar 6.
6
Signaling by the Epstein-Barr virus LMP1 protein induces potent cytotoxic CD4 and CD8 T cell responses.EB 病毒 LMP1 蛋白的信号转导诱导强烈的细胞毒性 CD4 和 CD8 T 细胞反应。
Proc Natl Acad Sci U S A. 2018 Jan 23;115(4):E686-E695. doi: 10.1073/pnas.1713607115. Epub 2018 Jan 8.
7
Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategies.针对 4-1BB 的免疫疗法:作用机制、临床结果和未来策略。
Blood. 2018 Jan 4;131(1):49-57. doi: 10.1182/blood-2017-06-741041. Epub 2017 Nov 8.
8
Mitochondrial Priming by CD28.CD28介导的线粒体启动
Cell. 2017 Oct 5;171(2):385-397.e11. doi: 10.1016/j.cell.2017.08.018. Epub 2017 Sep 14.
9
The landscape of genetic diseases in Saudi Arabia based on the first 1000 diagnostic panels and exomes.基于前1000个诊断面板和外显子组的沙特阿拉伯遗传疾病概况。
Hum Genet. 2017 Aug;136(8):921-939. doi: 10.1007/s00439-017-1821-8. Epub 2017 Jun 9.
10
Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency.遗传性CD70缺陷患者的联合免疫缺陷与爱泼斯坦-巴尔病毒诱导的B细胞恶性肿瘤
J Exp Med. 2017 Jan;214(1):91-106. doi: 10.1084/jem.20160849. Epub 2016 Dec 23.